| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
34,389 |
31,228 |
$1.49M |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
7,216 |
6,792 |
$542K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
19,980 |
18,533 |
$379K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,685 |
3,060 |
$99K |
| 64493 |
|
1,013 |
968 |
$83K |
| 62323 |
|
839 |
807 |
$78K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
5,540 |
1,655 |
$69K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
5,595 |
1,712 |
$53K |
| 64494 |
|
1,004 |
954 |
$40K |
| 64495 |
|
967 |
923 |
$39K |
| 77003 |
|
3,231 |
3,019 |
$26K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
5,783 |
5,361 |
$24K |
| 20610 |
|
1,022 |
957 |
$20K |
| 99406 |
|
6,623 |
5,857 |
$18K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
260 |
259 |
$17K |
| 77002 |
|
910 |
870 |
$16K |
| 80305 |
|
2,944 |
2,775 |
$14K |
| 97161 |
|
420 |
417 |
$12K |
| 97164 |
|
364 |
356 |
$12K |
| 97014 |
|
1,539 |
535 |
$9K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
1,269 |
709 |
$9K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
115 |
115 |
$7K |
| G0396 |
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes |
538 |
517 |
$4K |
| 1006F |
|
21,718 |
18,285 |
$3K |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
21,608 |
18,208 |
$2K |
| G8950 |
Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented |
14,346 |
12,506 |
$2K |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
17,690 |
15,291 |
$2K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
608 |
193 |
$2K |
| 1036F |
|
15,793 |
13,415 |
$2K |
| 3016F |
|
21,571 |
18,164 |
$2K |
| 97035 |
|
210 |
112 |
$1K |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
11,363 |
9,441 |
$1K |
| G9251 |
Documentation of patient with pain not brought to a comfortable level within 48 hours from initial assessment |
5,445 |
4,660 |
$946.42 |
| 97010 |
|
1,051 |
391 |
$934.31 |
| 96130 |
|
553 |
527 |
$523.96 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
2,325 |
2,030 |
$486.70 |
| 96132 |
|
204 |
191 |
$326.71 |
| 4004F |
|
5,694 |
4,971 |
$258.25 |
| 96138 |
|
494 |
470 |
$193.04 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
15 |
14 |
$155.09 |
| 99442 |
|
15 |
15 |
$123.50 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
5,630 |
5,082 |
$100.62 |
| G8421 |
Bmi not documented and no reason is given |
701 |
481 |
$50.52 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
16 |
13 |
$39.51 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
15 |
14 |
$17.43 |
| G8785 |
Blood pressure reading not documented, reason not given |
678 |
471 |
$16.68 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
55 |
53 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
48 |
45 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
219 |
214 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
47 |
45 |
$0.00 |
| G9250 |
Documentation of patient pain brought to a comfortable level within 48 hours from initial assessment |
224 |
217 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
32 |
31 |
$0.00 |